Kozajda Anna, Miśkiewicz Emilia
Nofer Institute of Occupational Medicine, Łódź, Poland (Department of Chemical Safety, Biological Safety Unit).
Int J Occup Med Environ Health. 2025 Mar 11;38(1):91-97. doi: 10.13075/ijomeh.1896.02522. Epub 2025 Jan 31.
This communication is aimed at outlining the role of the National Register of Biological Agents (NRoBA) in the system of working conditions supervision in Poland.
The paper was prepared based on a review of Polish legislation related to employee health protection, as well as scientific literature and recommendations of expert organizations regarding the intentional use of biological agents.
Polish law obliges employers to protect the health and safety of employees occupationally exposed to harmful agents. The State Sanitary Inspection and the State Labor Inspection supervise the employer's fulfillment of these obligations. Occupational exposure to biological agents may result from their intentional use (e.g., in the biotechnology industry or a scientific laboratory) or be related to their unintentional presence (e.g., in healthcare, sewage treatment plants, municipal waste management plants). Making a distinction between these 2 types of exposure is important for employers in relation to their legal obligations. In the case of using harmful biological agents for scientific, industrial or diagnostic purposes, the employer is obliged to notify the State Sanitary Inspection. Such notifications from employers are gathered in the NRoBA. Its aim is to support hygiene supervision over the intentional use of biological agents and to increase the employer's attention to the protection of the health of employees exposed to these agents. The International Labor Organization (ILO) in 2023 published , in which it recommended increasing the capacity for epidemiological surveillance by creating networks or dedicated websites to collect and analyze adverse events in employees of research and development laboratories. The NRoBA complies with these guidelines but in order to use it in epidemiological studies, it should be re-digitalized to extend the range of collected data.
The NRoBA in its present form has been used in Poland for almost 2 decades. Now it is time for re-digitalization to ensure its full compliance with the ILO recommendations and to use it in epidemiological studies. Int J Occup Med Environ Health. 2025;38(1):91-97.
本交流旨在概述波兰生物制剂国家登记册(NRoBA)在工作条件监督体系中的作用。
本文基于对波兰与员工健康保护相关的立法、科学文献以及专家组织关于生物制剂故意使用的建议进行综述而撰写。
波兰法律规定雇主有义务保护职业接触有害制剂的员工的健康和安全。国家卫生检查局和国家劳动检查局监督雇主履行这些义务的情况。职业接触生物制剂可能源于其故意使用(例如在生物技术行业或科学实验室),也可能与其意外存在有关(例如在医疗保健、污水处理厂、城市垃圾管理厂)。区分这两种接触类型对雇主履行其法律义务很重要。在将有害生物制剂用于科学、工业或诊断目的的情况下,雇主有义务通知国家卫生检查局。雇主的此类通知收集在NRoBA中。其目的是支持对生物制剂故意使用的卫生监督,并提高雇主对保护接触这些制剂的员工健康的关注度。国际劳工组织(ILO)在2023年发布了 ,其中建议通过创建网络或专门网站来收集和分析研发实验室员工的不良事件,以提高流行病学监测能力。NRoBA符合这些指导方针,但为了在流行病学研究中使用它,应重新进行数字化处理以扩大收集数据的范围。
目前形式的NRoBA在波兰已使用了近20年。现在是时候进行重新数字化处理,以确保其完全符合国际劳工组织的建议,并将其用于流行病学研究。《国际职业医学与环境卫生杂志》。2025年;38(1):91 - 97。